K2 Medical Research, LLC
Orlando, Florida 32751
0 studies enrolling now · 2 studies all time
What they study most
Alzheimer's Disease, Alzheimer's Disease Dementia, Mild Cognitive Impairment Due to Alzheimer's Disease
Studies at this site
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
- A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early